Lixin Wang, Haibing He, Xing Tang, Ruiying Shao, Dawei Chen
Liaoning Medical Apparatus and Instrument Institute, Shen Yang 110000, People's Republic of China.
Int J Pharm. 2006 Oct 12;323(1-2):161-7. doi: 10.1016/j.ijpharm.2006.05.060. Epub 2006 Jun 3.
Lipid microspheres (LM) have recently been used as intravenous (i.v.) carriers for drugs, which are sufficiently soluble in oil. However, in the case of norcantharidin (NCTD), which is poorly soluble in both the water and oil phases, this approach is not feasible. In this study, NCTD-loaded LM was prepared by transferring the drug to the interfacial surface of the oil and aqueous phases to produce a less irritating i.v. formulation of NCTD. A probe type sonicator was used to disperse NCTD into the oil phase together with lecithin and Tween 80. A high-pressure homogenization process was used to prepare the lipid microspheres and localize the drug at the surfactant layer. The LM loaded with NCTD consisted of 0.02% drug. Characterization of LMs and short-term stability was performed by photon correlation spectroscopy (PCS) and a centrifugation test was also carried out. The results showed that NCTD-loaded LM (2 mg/ml) with over 80% NCTD loaded in the interfacial surface were stable for a period of 2 months, and were suitable for i.v. injection in terms of size and stability, whether be diluted or not. Such formulations produced less pain and irritation in animal studies.
脂质微球(LM)最近被用作油溶性药物的静脉内(i.v.)载体。然而,对于在水相和油相中均难溶的去甲斑蝥素(NCTD)而言,这种方法不可行。在本研究中,通过将药物转移至油相和水相的界面表面来制备载NCTD的LM,以生产刺激性较小的NCTD静脉内制剂。使用探针型超声仪将NCTD与卵磷脂和吐温80一起分散到油相中。采用高压均质化工艺制备脂质微球并将药物定位在表面活性剂层。载NCTD的LM含0.02%的药物。通过光子相关光谱法(PCS)对LM进行表征并进行短期稳定性研究,同时还进行了离心试验。结果表明,超过80%的NCTD负载于界面表面的载NCTD的LM(2 mg/ml)在2个月内稳定,无论是否稀释,其大小和稳定性均适合静脉注射。此类制剂在动物研究中产生的疼痛和刺激较小。